On Aug. 21, 2019, Pfizer announced that it is investing an additional half billion-dollar investment for the construction of its state-of-the-art gene therapy manufacturing facility in Sanford, NC. The facility will support Pfizer s continuing investment in gene therapy R&D, similar to PfizeOriginal Article
You may also like
FDA Approves SpringWorks Therapeutics Treatment for...
ADVANCEMENTS IN GLP-1 ANALOG FORMULATION DEVELOPMENT:...
Axplora Announces €50 Million Investment in GLP-1...
Drug Digest: Advances in Small-Molecule Manufacturing
Navigating Drug Development: The Critical Role of...
MMS Acquires Exploristics and Its Flagship Modeling...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.